The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Increase Is Anticipated For The Cardiovascular Implants Market Over The 2026–2030 Period?
The cardiovascular implants market has demonstrated substantial growth over recent years. This market is expected to expand from $28.68 billion in 2025 to $30.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.4%. Historically, this growth can be ascribed to factors such as the increasing prevalence of cardiovascular diseases, a rise in interventional cardiology procedures, the expansion of hospital cardiac care units, the growing adoption of implantable pacemakers, and the availability of advanced biomaterials.
The cardiovascular implants market size is anticipated to experience substantial growth in the coming years. It is projected to reach $39.09 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. This projected expansion during the forecast period is driven by factors such as an expanding aging population, a growing demand for minimally invasive cardiac interventions, the development of structural heart disease therapies, an increased emphasis on personalized cardiovascular care, and advancements in implant materials and designs. Key developments expected during this period involve the rising adoption of minimally invasive cardiovascular implants, the increased application of drug-eluting and bioabsorbable stents, a preference for transcatheter heart valve procedures, the proliferation of advanced cardiac rhythm management devices, and a stronger focus on the long-term durability of implants.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13399&type=smp
What Underlying Factors Are Accelerating The Growth Of The Cardiovascular Implants Market?
The increasing occurrence of heart disorders is anticipated to propel the expansion of the cardiovascular implants market moving forward. These cardiac conditions encompass various medical ailments impacting the heart and blood vessels, such as coronary artery disease, heart failure, arrhythmias, and valve issues. The widespread existence of these heart diseases, like coronary artery disease and heart failure, fuels the demand for cardiovascular implants, including stents and pacemakers, used to treat these conditions. These implants provide support to the heart and circulation for patients with heart failure, help regulate the heart’s rhythm, and monitor cardiac activity. For instance, in September 2024, a report from the British Heart Foundation (BHF), a UK charity funding research and promoting awareness of heart and circulatory diseases, revealed that approximately 7.6 million individuals in the UK are currently affected by such conditions. Furthermore, it is projected that by 2030, the number of people living with heart and circulatory diseases in the UK could increase by 1 million, and by 2040, this figure may rise by an additional 2 million compared to present numbers. Consequently, the escalating prevalence of heart disorders is a key driver for the growth of the cardiovascular implants market.
How Is The Cardiovascular Implants Market Segmented Across Key Categories?
The cardiovascular implants market covered in this report is segmented –
1) By Product: Coronary Stent, Implantable Cardioverter Defibrillator (ICD), Heart Valve, Implanted Cardiac Pacemaker, Cardiac Resynchronization Therapy (CRT) Devices, Peripheral Stent
2) By Material: Metals and Alloys, Polymers, Biological Materials
3) By Application: Arrhythmias, Acute Myocardial Infarction, Myocardial Ischemia, Other Applications
4) By End-Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers
Subsegments:
1) By Coronary Stent: Drug-Eluting Stents, Bare-Metal Stents, Bioabsorbable Stents
2) By Implantable Cardioverter Defibrillator (ICD): Single-Chamber ICD, Dual-Chamber ICD, Biventricular ICD
3) By Heart Valve: Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves
4) By Implanted Cardiac Pacemaker: Single-Chamber Pacemaker, Dual-Chamber Pacemaker, Biventricular Pacemaker
5) By Cardiac Resynchronization Therapy (CRT) Devices: CRT-P Devices (Pacemakers), CRT-D Devices (Defibrillators)
6) By Peripheral Stent: Carotid Artery Stents, Renal Artery Stents, Femoral Artery Stents
Which Upcoming Trends Are Expected To Influence The Cardiovascular Implants Market?
Major companies operating in the cardiovascular implants market are increasingly focusing on incorporating advanced artificial intelligence (AI) technology to boost their profits and enhance the precision of patient care and treatment. The progression in cardiac monitoring technology involves the continuous tracking and recording of a patient’s heart activity to facilitate the diagnosis and management of various heart conditions. For example, in June 2023, BIOTRONIK SE & Co. KG, a medical technology firm from Germany, launched the world’s first implantation of its BIOMONITOR IV implantable cardiac monitor (ICM). This BIOMONITOR IV is an innovative ICM that integrates BIOTRONIK’s SmartECG technology with artificial intelligence, aiming to decrease false-positive detections by 86% while successfully retaining 98% of genuine episodes. Beyond its sophisticated artificial intelligence capabilities, BIOMONITOR IV provides numerous other advantages for patients and healthcare providers, including extended battery life and wireless connectivity, which enable smooth data transmission and remote monitoring, thereby minimizing the need for frequent in-person clinic visits.
Who Are The Dominant Players Shaping The Cardiovascular Implants Market Landscape?
Major companies operating in the cardiovascular implants market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Cook Medical Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Proxy Biomedical Ltd., Calon Cardio-Technology Ltd., InspireMD Inc., Neovasc Inc., Shree Pacetronix Ltd., Vascutek Ltd
Read the full cardiovascular implants market report here:
https://www.thebusinessresearchcompany.com/report/cardiovascular-implants-global-market-report
Which Region Is Projected To Dominate The Cardiovascular Implants Market During The Forecast Period?
North America was the largest region in the cardiovascular implants market in 2025. The regions covered in the cardiovascular implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Cardiovascular Implants Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=13399&type=smp
Browse Through More Reports Similar to the Global Cardiovascular Implants Market 2026, By The Business Research Company
Cardiovascular Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report
Cardiovascular Surgery Devices And Equipment Market Report 2026
Cardiovascular Monitoring And Diagnostic Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model